Abbott Laboratories Announces Measurable Results From LATAM Diagnostic Market Development and Training Initiative Led by Claudia Marcela Riaño Caro 
Illumina completes acquisition of SomaLogic
Deeply expands leadership in proteomics and multiomicsCombined capabilities bring high scalability, flexibility, and affordability into protein analysis Combination leverages SomaScan with Illumina's...
RazorMetrics Drives More Than $11 Million in Prescription Drug Savings for Ohio Plans and Residents
AUSTIN, Texas, Jan. 30, 2026 /PRNewswire/ -- RazorMetrics, a leading innovator in pharmacy cost containment technology, today announced that it...
NYSE Content Advisory: Pre-Market Update + Cast of HBO’s ‘Industry’ Rang Thursday’s Closing Bell
NEW YORK, Jan. 30, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from...
VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays
HENDERSON, Nev., Jan. 30, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the...
Lyric Health Appoints Bill Schmitt as Chief Growth Officer to Accelerate AI-Powered Virtual Care Growth
MCKINNEY, Texas, Jan. 30, 2026 /PRNewswire/ -- Lyric Health, a leader in AI-powered virtual care and integrated health navigation, today announced...
Activity Connection and Zinnia TV Partner to Advance Person-Centered Care in Senior Living Through Integrated Life Enrichment and Digital Engagement
VANCOUVER, Wash., Jan. 30, 2026 /PRNewswire/ -- Activity Connection and Zinnia TV today announced a strategic partnership to integrate structured...
Soundtrace Completes Independent Third-Party Review Confirming Alignment With OSHA Hearing Conservation Requirements
Former Senior OSHA Leader Evaluates Program Against 29 CFR 1910.95CINCINNATI, Jan. 30, 2026 /PRNewswire/ -- Soundtrace, a technology-enabled services company...
Breg Achieves HITRUST Certification for Breg Vision® and Vision Clarity™
CARLSBAD, Calif., Jan. 30, 2026 /PRNewswire/ -- Breg today announced that it has successfully achieved HITRUST certification, underscoring the company's...
Understanding When to Use Fillers or Neurotoxins According to Dr. Ran Rubinstein
Dr. Ran Rubinstein discusses how individualized treatment planning determines when fillers, neurotoxins, or collagen-stimulating injectables are most appropriate. MONTVALE, NEW...
Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets
PALO ALTO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative...
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
TAIZHOU, China, Jan. 30, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”), a specialty...
Amplia Therapeutics – Quarterly Activities and Cash Flow Reports – December 2025
Melbourne, Australia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Key Highlights from the Quarter ACCENT Trial Success: The ACCENT trial, testing...
ALX Oncology Announces Pricing of Underwritten Offering
SOUTH SAN FRANCISCO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Oncology,” Nasdaq: ALXO), a clinical-stage...
Ultragenyx Resubmits Biologics License Application for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA) to U.S. FDA
Company expects up to six-month review period per FDA guidelines New longer-term clinical data demonstrating durable positive brain biochemical and...
Jyong Biotech Subsidiary Announces Phase II Clinical Data on Cholesterol and LDH Indicators for MCS-8 (PCP), Indicating Potential in Prostate Cancer Prevention and Metabolic Value
New Taipei City, Taiwan, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”),...
New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology’s Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer
- Exploratory analysis from Phase 1b/2 breast cancer trial reinforces CD47 as a predictive biomarker for response, as previously observed...
IO Biotech Provides Corporate Update
Raymond James engaged as financial advisorReduction in force implemented NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq:...
Polaryx Therapeutics Announces Approval to List Common Stock on Nasdaq
PARAMUS, NJ, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics (“Polaryx” or the “Company”) a clinical-stage biotechnology company dedicated to...
Delivra Health Brands Announces Appointment of New Director
Vancouver, British Columbia--(Newsfile Corp. - January 30, 2026) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health", "Delivra" or the...
KITS Eyecare Announces Expanded 2026 Pangolin Smart Glasses Lineup and Launch of KITS App
After selling out all previous Pangolin versions, KITS will release three additional Pangolin 3 Video and Photo enabled designs in...